CUE BIOPHARMA, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.65 USD | -5.17% |
|
-20.67% | -37.50% |
| May. 09 | Cue Biopharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Apr. 08 | Transcript : Cue Biopharma, Inc., Q4 2023 Earnings Call, Apr 08, 2024 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CUE BIOPHARMA, INC. | Bio Therapeutic Drugs | -5.17% | -20.67% | -37.50% | -61.63% | -79.70% | 80.26M |  | |  |
Technical Rankings Surperformance
- Stock Market
- Equities
- CUE Stock
- Charts Cue Biopharma, Inc.
- Comparison Chart